The Limb Salvage Center

Filter Your Results




FDA Approves Bevyxxa for Hospital and Extended-Duration VTE Prevention in Acutely Ill Patients

June 28, 2017 -- Portola Pharmaceuticals Inc. recently announced that the US Food and Drug Administration (FDA) has approved Bevyxxa (betrixaban) for hospital and extended-dur…

Key Milestones Announced for Shockwave Medical's Lithoplasty System in Treatment of PAD

June 21, 2017 -- Shockwave Medical, Inc. announced two milestones for its Lithoplasty system for the treatment of calcified plaque in patients with peripheral artery disease (…

Walk Vascular's Jeti Thrombectomy System Approved in United States and Europe

June 21, 2017 -- Walk Vascular, LLC announced US Food and Drug Administration clearance and European CE Mark approval of its Jeti thrombectomy system, which is indicated for u…

Evaluating the Legflow Device in the LEG-DEB Registry

Eugenio Stabile, MD, PhD

May 2017—A new generation of DCBs could achieve superiority in treating BTK arteries.

PRELUDE Enrollment Completed for Cagent Vascular's Serranator Alto PTA Device

June 5, 2017 -- Cagent Vascular announced the completion of enrollment in the first-in-human PRELUDE study of the company's Serranator Alto percutaneous transluminal angio…

Philips Relaunches the Pioneer Plus Catheter

June 1, 2017 -- Philips Volcano announced the relaunch of the Pioneer Plus catheter, a re-entry device with intravascular ultrasound capabilities and needle deployment designe…

First-in-Human Study of Med Alliance's Selution DCB Completes Enrollment

May 30, 2017 -- Med Alliance Group, Inc., a Switzerland-based company, announced completion of patient enrollment in the first-in-human (FIH) evaluation of the Selution siroli…

Complete 24-Month Data Presented From the Pivotal VISION Study of Avinger's Lumivascular Technology

May 31, 2017 -- Avinger, Inc. announced positive 2-year clinical data from the pivotal VISION study of the company’s Lumivascular technology for use in the treatment of …




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.